Boothbay Fund Management LLC 13D and 13G filings for Forte Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-07 2:43 pm Sale | 2025-06-30 | 13G | Forte Biosciences, Inc. FBRX | Boothbay Fund Management LLC | 53,791 0.800% | -34,994 (-39.41%) | Filing |
| 2025-02-13 11:20 am Purchase | 2024-12-31 | 13G | Forte Biosciences, Inc. FBRX | Boothbay Fund Management LLC | 88,785 6.000% | 88,785 (New Position) | Filing |